Assessment report on Gentiana lutea L., radix
Committee on Herbal Medicinal Products (HMPC)
Published in European Medicines Agency
Methodology
Regulatory assessment of the published clinical, preclinical and safety literature on gentian root preparations.
Key Findings
Gentian root qualifies only for traditional-use registration for temporary loss of appetite and mild dyspepsia; no adequate controlled clinical trials of the single herb exist.
Conclusions
Gentian use rests on traditional evidence, not controlled clinical trial data.
Limitations
Regulatory review, not a quantitative synthesis; based on longstanding-use criteria.
Supplements Studied
Gentian root qualifies only for traditional use in temporary loss of appetite and mild dyspeptic complaints; no adequate controlled clinical trials of the single herb exist.
Outcomes Measured
Gentian root is accepted for traditional use in temporary loss of appetite and mild dyspeptic complaints.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.